ONCT · Categories · Form 4

ONCT - SEC Form 4 insider transactions

Oncternal Therapeutics Inc. (ONCT) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ONCT

• 710d
  SEC Form 4 filed by Director Kisner Daniel L

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 710d
  SEC Form 4 filed by Director Carter Michael G

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 710d
  SEC Form 4 filed by Director Larue William R

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 710d
  SEC Form 4 filed by Director Desimone Jill

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 710d
  SEC Form 4 filed by Director Theuer Charles

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 710d
  SEC Form 4 filed by Director Hale David F

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 710d
  SEC Form 4 filed by Director Wills Robert James

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 710d
  SEC Form 4 filed by Director Mazanet Rosemary

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 828d
  Wills Robert James sold $8,859 worth of shares (980 units at $9.04), closing all direct ownership in the company (SEC Form 4)

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 840d
  SEC Form 4 filed by Breitmeyer James B

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 840d
  SEC Form 4 filed by Leavitt Chase C.

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 840d
  SEC Form 4 filed by Yazji Salim

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 840d
  SEC Form 4 filed by Krishnan Rajesh

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 840d
  SEC Form 4 filed by Vincent Richard G

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 881d
  Krishnan Rajesh covered exercise/tax liability with 11,838 shares, decreasing direct ownership by 21% to 44,019 units (SEC Form 4)

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 881d
  Yazji Salim covered exercise/tax liability with 19,742 shares, decreasing direct ownership by 13% to 128,635 units (SEC Form 4)

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 881d
  Vincent Richard G covered exercise/tax liability with 8,868 shares, decreasing direct ownership by 6% to 140,922 units (SEC Form 4)

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 881d
  Leavitt Chase C. covered exercise/tax liability with 11,838 shares, decreasing direct ownership by 12% to 84,758 units (SEC Form 4)

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 881d
  Breitmeyer James B covered exercise/tax liability with 55,440 shares, decreasing direct ownership by 10% to 443,034 units (SEC Form 4)

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 974d
  SEC Form 4 filed by Leavitt Chase C.

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 974d
  SEC Form 4 filed by Yazji Salim

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 974d
  SEC Form 4 filed by Breitmeyer James B

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 974d
  SEC Form 4 filed by Vincent Richard G

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 974d
  SEC Form 4 filed by Krishnan Rajesh

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1065d
  SEC Form 4 filed by Breitmeyer James B

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1065d
  SEC Form 4 filed by Leavitt Chase C.

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1065d
  SEC Form 4 filed by Vincent Richard G

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1065d
  SEC Form 4 filed by Yazji Salim

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1065d
  SEC Form 4 filed by Krishnan Rajesh

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1070d
  SEC Form 4 filed by Mazanet Rosemary

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1070d
  SEC Form 4 filed by Larue William R

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1070d
  SEC Form 4 filed by Carter Michael G

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1070d
  SEC Form 4 filed by Theuer Charles

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1070d
  SEC Form 4 filed by Hale David F

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1070d
  SEC Form 4 filed by Kisner Daniel L

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1070d
  SEC Form 4 filed by Desimone Jill

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1070d
  SEC Form 4 filed by Nakanishi Xin

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1070d
  SEC Form 4 filed by Wills Robert James

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1086d
  SEC Form 4 filed by Kaufmann Gunnar F.

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1145d
  SEC Form 4 filed by Breitmeyer James B

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1147d
  SEC Form 4 filed by Yazji Salim

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1148d
  SEC Form 4 filed by Vincent Richard G

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1148d
  SEC Form 4 filed by Leavitt Chase C.

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1196d
  SEC Form 4 filed by Breitmeyer James B

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1197d
  SEC Form 4 filed by Yazji Salim

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1197d
  SEC Form 4 filed by Leavitt Chase C.

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1197d
  SEC Form 4 filed by Vincent Richard G

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1197d
  SEC Form 4 filed by Krishnan Rajesh

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1197d
  SEC Form 4 filed by Kaufmann Gunnar F.

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1246d
  SEC Form 4 filed by Desimone Jill

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1246d
  SEC Form 4: Breitmeyer James B covered exercise/tax liability with 29,118 shares, decreasing direct ownership by 5% to 541,981 units (tax withholding)

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1246d
  SEC Form 4: Krishnan Rajesh covered exercise/tax liability with 6,238 shares, decreasing direct ownership by 9% to 66,754 units to cover withholding tax

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1246d
  SEC Form 4: Leavitt Chase C. covered exercise/tax liability with 6,091 shares, decreasing direct ownership by 7% to 81,901 units to cover withholding tax

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1246d
  SEC Form 4: Yazji Salim covered exercise/tax liability with 9,961 shares, decreasing direct ownership by 7% to 139,676 units (withholding obligation)

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1246d
  SEC Form 4: Kaufmann Gunnar F. covered exercise/tax liability with 6,266 shares, decreasing direct ownership by 9% to 66,726 units (withholding obligation)

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1246d
  SEC Form 4: Vincent Richard G covered exercise/tax liability with 4,428 shares, decreasing direct ownership by 3% to 126,859 units to satisfy tax liability

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1403d
  SEC Form 4: Leavitt Chase C. was granted 43,125 shares, increasing direct ownership by 96% to 87,992 units

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1403d
  SEC Form 4: Kaufmann Gunnar F. was granted 43,125 shares, increasing direct ownership by 144% to 72,992 units

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1403d
  SEC Form 4: Krishnan Rajesh was granted 43,125 shares, increasing direct ownership by 144% to 72,992 units

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)
• 1403d
  SEC Form 4: Vincent Richard G was granted 43,125 shares, increasing direct ownership by 49% to 131,287 units

  4 - Oncternal Therapeutics, Inc. (0001260990) (Issuer)

Other ONCT categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends